Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,964,750
-
Total 13F shares
-
37,247,837
-
Share change
-
-4,076,585
-
Total reported value
-
$416,814,941
-
Put/Call ratio
-
36%
-
Price per share
-
$11.19
-
Number of holders
-
115
-
Value change
-
-$42,220,620
-
Number of buys
-
53
-
Number of sells
-
60
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2016
As of 30 Jun 2016 Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) had 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,247,837 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT CO, Palo Alto Investors, LLC, PAULSON & CO. INC., GREAT POINT PARTNERS LLC, MORGAN STANLEY, VANGUARD GROUP INC, MACQUARIE GROUP LTD, BlackRock Fund Advisors, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This table shows 115 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.